A key challenge in the selection of treatment for patients with Crohn’s disease (CD) is the lack of tools to identify the patients that have the highest likelihood of achieving remission with biologic treatments. Recently a clinical decision support tool (CDST) has been developed using key clinical, imaging, and laboratory markers. This tool is specifically designed for patients with high burden of disease. The tool assesses disease burden, uses risk and clinical/laboratory data to predict outcomes for certain drugs, and includes additional resources explaining how the prediction is calculated. Join Dr. Sandborn in a virtual demonstration of the tool using patient case vignettes.
Upon completion of this activity, participants should be better able to:
Assistant Professor
UC San Diego School of Medicine
San Diego, CA
Assistant Clinical Professor
UC San Diego School of Medicine
San Diego, CA
Professor, Medicine
Adjunct Professor, Surgery
Chief, Division of Gastroenterology
Vice Chair, Clinical Operations
Department of Medicine
Director, UCSD IBD Center
UC San Diego Health System
San Diego, CA
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources